• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用儿童和成人初次接种、成人再次接种和剂量反应以及免疫功能低下个体研究的数据验证黄热病疫苗模型。

Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.

机构信息

Institute of Education, Science and Technology of Southeast of Minas Gerais - Cataguases Advanced Campus, Chácara Granjaria, s/n - Granjaria, 36773-563, Cataguases, Brazil.

Medical School, Presidente Antônio Carlos University, Juiz de Fora, Brazil.

出版信息

BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):551. doi: 10.1186/s12859-020-03845-3.

DOI:10.1186/s12859-020-03845-3
PMID:33308151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7733702/
Abstract

BACKGROUND

An effective yellow fever (YF) vaccine has been available since 1937. Nevertheless, questions regarding its use remain poorly understood, such as the ideal dose to confer immunity against the disease, the need for a booster dose, the optimal immunisation schedule for immunocompetent, immunosuppressed, and pediatric populations, among other issues. This work aims to demonstrate that computational tools can be used to simulate different scenarios regarding YF vaccination and the immune response of individuals to this vaccine, thus assisting the response of some of these open questions.

RESULTS

This work presents the computational results obtained by a mathematical model of the human immune response to vaccination against YF. Five scenarios were simulated: primovaccination in adults and children, booster dose in adult individuals, vaccination of individuals with autoimmune diseases under immunomodulatory therapy, and the immune response to different vaccine doses. Where data were available, the model was able to quantitatively replicate the levels of antibodies obtained experimentally. In addition, for those scenarios where data were not available, it was possible to qualitatively reproduce the immune response behaviours described in the literature.

CONCLUSIONS

Our simulations show that the minimum dose to confer immunity against YF is half of the reference dose. The results also suggest that immunological immaturity in children limits the induction and persistence of long-lived plasma cells are related to the antibody decay observed experimentally. Finally, the decay observed in the antibody level after ten years suggests that a booster dose is necessary to keep immunity against YF.

摘要

背景

自 1937 年以来,已经有一种有效的黄热病(YF)疫苗。然而,关于其使用的问题仍然知之甚少,例如能够产生针对该疾病免疫力的理想剂量、是否需要加强剂量、免疫能力正常、免疫抑制和儿科人群的最佳免疫接种计划等问题。这项工作旨在表明,计算工具可以用于模拟与 YF 疫苗接种和个体对这种疫苗的免疫反应有关的不同情况,从而有助于回答其中一些悬而未决的问题。

结果

这项工作展示了针对 YF 疫苗接种的人类免疫反应的数学模型所获得的计算结果。模拟了五个方案:成人和儿童的初次接种、成人的加强剂量、接受免疫调节治疗的自身免疫性疾病患者的接种,以及不同疫苗剂量的免疫反应。在有数据的情况下,该模型能够定量复制实验中获得的抗体水平。此外,对于那些没有数据的方案,能够定性再现文献中描述的免疫反应行为。

结论

我们的模拟表明,能够产生针对 YF 免疫力的最小剂量是参考剂量的一半。结果还表明,儿童的免疫不成熟限制了诱导和维持长寿浆细胞的能力,这与实验中观察到的抗体衰减有关。最后,十年后抗体水平的衰减表明需要加强剂量来保持对 YF 的免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/dc41a5951dde/12859_2020_3845_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/9be9acaede00/12859_2020_3845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/0a58e8144d8f/12859_2020_3845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/d18a090cac83/12859_2020_3845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/7048b9b67f09/12859_2020_3845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/1274923e1e14/12859_2020_3845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/eb19a7ce6ade/12859_2020_3845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/cd1d7ceb1c79/12859_2020_3845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/f5188bae6471/12859_2020_3845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/9457384cda82/12859_2020_3845_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/dc41a5951dde/12859_2020_3845_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/9be9acaede00/12859_2020_3845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/0a58e8144d8f/12859_2020_3845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/d18a090cac83/12859_2020_3845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/7048b9b67f09/12859_2020_3845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/1274923e1e14/12859_2020_3845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/eb19a7ce6ade/12859_2020_3845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/cd1d7ceb1c79/12859_2020_3845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/f5188bae6471/12859_2020_3845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/9457384cda82/12859_2020_3845_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fd/7735422/dc41a5951dde/12859_2020_3845_Fig10_HTML.jpg

相似文献

1
Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.使用儿童和成人初次接种、成人再次接种和剂量反应以及免疫功能低下个体研究的数据验证黄热病疫苗模型。
BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):551. doi: 10.1186/s12859-020-03845-3.
2
A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine.一种经质量验证的黄热病疫苗免疫反应的数学计算模型。
BMC Immunol. 2018 May 25;19(1):15. doi: 10.1186/s12865-018-0252-1.
3
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.单次接种 17DD 黄热病减毒活疫苗后短暂的免疫持久性表明,为保证儿童的保护性免疫,可能需要加强免疫接种。
Front Immunol. 2019 Sep 26;10:2192. doi: 10.3389/fimmu.2019.02192. eCollection 2019.
4
Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.加强型黄热病疫苗接种的免疫反应极小,与预先存在的抗体有关。
Vaccine. 2020 Feb 24;38(9):2172-2182. doi: 10.1016/j.vaccine.2020.01.045. Epub 2020 Jan 31.
5
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.免疫激活会改变对黄热病17D疫苗的细胞和体液反应。
J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9.
6
Duration of post-vaccination humoral immunity against yellow fever in children.儿童接种黄热病疫苗后体液免疫的持续时间。
Vaccine. 2019 Nov 15;37(48):7147-7154. doi: 10.1016/j.vaccine.2019.09.051. Epub 2019 Oct 4.
7
Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?9至15个月大儿童对黄热病和麻疹疫苗免疫反应的观察性研究。两种减毒活疫苗之间有必要间隔4周吗?
Vaccine. 2015 May 11;33(20):2301-6. doi: 10.1016/j.vaccine.2015.03.069. Epub 2015 Apr 2.
8
Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.黄热病病毒特异性中和抗体在接种疫苗后在美国旅行者中的持久性。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay108.
9
Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.两剂 17DD 黄热病疫苗接种者的免疫持续时间。
Vaccine. 2019 Aug 14;37(35):5129-5135. doi: 10.1016/j.vaccine.2019.05.048. Epub 2019 Jun 3.
10
Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.黄热病疫苗接种后的效力和免疫持续时间:关于每 10 年加强免疫的必要性的系统评价。
Am J Trop Med Hyg. 2013 Sep;89(3):434-44. doi: 10.4269/ajtmh.13-0264.

引用本文的文献

1
Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine.聚乙烯亚胺作为佐剂的潜力:用于制备长效且强效抗真菌纳米疫苗。
Front Immunol. 2022 May 16;13:843684. doi: 10.3389/fimmu.2022.843684. eCollection 2022.
2
Toward computational modelling on immune system function.朝向免疫系统功能的计算建模。
BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):546. doi: 10.1186/s12859-020-03897-5.

本文引用的文献

1
A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria.一种针对可怕的人类疟疾的多表位口服疫苗的免疫信息学设计的前沿方法。
Int J Biol Macromol. 2020 Sep 1;158:159-179. doi: 10.1016/j.ijbiomac.2020.04.191. Epub 2020 Apr 29.
2
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.利用免疫信息学工具进行更好的表位发现、精准免疫工程和加速疫苗设计。
Front Immunol. 2020 Apr 7;11:442. doi: 10.3389/fimmu.2020.00442. eCollection 2020.
3
Computer aided novel antigenic epitopes selection from the outer membrane protein sequences of Aeromonas hydrophila and its analyses.
基于嗜水气单胞菌外膜蛋白序列的计算机辅助新型抗原表位筛选及其分析
Infect Genet Evol. 2020 Aug;82:104320. doi: 10.1016/j.meegid.2020.104320. Epub 2020 Apr 13.
4
An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.基于实验蛋白质组学的免疫信息学方法:针对利什曼原虫无鞭毛体分泌蛋白的亚单位候选疫苗的计算机设计。
Parasit Vectors. 2020 Apr 15;13(1):196. doi: 10.1186/s13071-020-04064-8.
5
Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches.基于表位的疫苗设计:生物信息学方法的全面概述。
Drug Discov Today. 2020 Jun;25(6):1034-1042. doi: 10.1016/j.drudis.2020.03.006. Epub 2020 Mar 20.
6
Identification of potential therapeutic targets in Neisseria gonorrhoeae by an in-silico approach.通过计算机模拟方法鉴定淋病奈瑟菌中的潜在治疗靶点
J Theor Biol. 2020 Apr 7;490:110172. doi: 10.1016/j.jtbi.2020.110172. Epub 2020 Jan 20.
7
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS).使用通用免疫系统模拟器(UISS)预测 RUTI® 疫苗对结核病的人工免疫。
BMC Bioinformatics. 2019 Dec 10;20(Suppl 6):504. doi: 10.1186/s12859-019-3045-5.
8
Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system.通过将裂谷热糖蛋白Gn与霍乱毒素(CTB)的强佐剂亚基B进行基因连接并在细菌系统中表达来开发裂谷热(RVF)疫苗。
Saudi J Biol Sci. 2019 Nov;26(7):1676-1681. doi: 10.1016/j.sjbs.2018.08.019. Epub 2018 Aug 22.
9
Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.两剂 17DD 黄热病疫苗接种者的免疫持续时间。
Vaccine. 2019 Aug 14;37(35):5129-5135. doi: 10.1016/j.vaccine.2019.05.048. Epub 2019 Jun 3.
10
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.合成和生物免疫调节疗法对类风湿关节炎患者 17DD 黄热病疫苗诱导免疫持续时间的影响。
Arthritis Res Ther. 2019 Mar 14;21(1):75. doi: 10.1186/s13075-019-1854-6.